References
- Bralley EE, Greenspan P, Hargrove JL, et al. (2008). Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation. J Inflamm (Lond) 5:1--7
- Calhoun ME, Jucker M, Martin LJ, et al. (1996). Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol 25:821–8
- Cheng WS, Xu JP, Yin XP, et al. (2001). Application of emodin-8-O-beta-d-glucoside. Chinese Patent, publication number: CN1114413C
- Chu X, Sun A, Liu R. (2005). Preparative isolation and purification of five compounds from the Chinese medicinal herb Polygonum cuspidatum Sieb. et Zucc by high-speed counter-current chromatography. J Chromatogr A 1097:33–9
- Davies CA, Mann DM, Sumpter PQ, et al. (1987). A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease. J Neurol Sci 78:151–64
- Dineley KT. (2007). beta-Amyloid peptide – nicotinic acetylcholine receptor interaction: The two faces of health and disease. Front Biosci 12:5030–8
- Du QH, Peng C, Zhang H. (2013). Polydatin: A review of pharmacology and pharmacokinetics. Pharm Biol. [Epub ahead of print]. doi:10.3109/13880209.2013.792849
- Goto S, Hirano A. (1990). Neuronal inputs to hippocampal formation in Alzheimer’s disease and in parkinsonism-dementia complex on Guam. Acta Neuropathol 79:545–50
- Guan ZZ, Miao H, Tian JY, et al. (2001). Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells. J Neural Transm 108:1417–33
- Guan ZZ, Yu WF, Shan KR, et al. (2003). Loss of nicotinic receptors induced by beta-amyloid peptides in PC12 cells: Possible mechanism involving lipid peroxidation. J Neurosci Res 71:397–406
- Kim SH, Jang SD, Lee KY, et al. (2009). Chemical constituents isolated from Polygala japonica leaves and their inhibitory effect on nitric oxide production in vitro. J Enzyme Inhib Med Chem 24:230–3
- Liu Q, Kawai H, Berg DK. (2001). Beta-amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci USA 98:4734–9
- Manila E, Talvitie A, Kolehmainen E. (1993). Anti-leukaemic compounds derived from stilbenes in Picea abies bark. Phytochemistry 33:813–16
- Parri HR, Hernandez CM, Dineley KT. (2011). Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer’s disease. Biochem Pharmacol 82:931–42
- Prince M, Bryce R, Ferri C. (2011). World Alzheimer Report 2011: The Benefits of Early Diagnosis and Intervention. London: Alzheimer’s Disease International
- Qi LW, Li P, Li SL, et al. (2006). Screening and identification of permeable components in a combined prescription of Danggui Buxue decoction using a liposome equilibrium dialysis system followed by HPLC and LC-MS. J Sep Sci 29:2211–20
- Scheff SW, Price DA. (2003). Synaptic pathology in Alzheimer’s disease: A review of ultrastructural studies. Neurobiol Aging 24:1029–46
- Shimohama S, Kihara T. (2001). Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity. Biol Psychiatry 49:233–9
- Tang Z, An Y, Qi XL, et al. (2008). Inhibiting gene expression of alpha3 nicotinic receptor in SH-SY5Y cells with the effects on APP metabolism and antioxidation in Alzheimer’s disease. Neurochem Int 53:112–17
- Wang C, Zhang D, Ma H, et al. (2007). Neuroprotective effects of emodin-8-O-beta-d-glucoside in vivo and in vitro. Eur J Pharmacol 577:58–63
- Xiang L, Lei F, Xing DM, et al. (2005). Neuron protective constituents from rheum nanum and rheum sublanceolatum. Tsinghua Sci Technol 10:426–9
- Yang F, Zhang T, Ito Y. (2001). Large-scale separation of resveratrol, anthraglycoside A and anthraglycoside B from Polygonum cuspidatum Sieb. et Zucc by high-speed counter-current chromatography. J Chromatogr A 919:443–8